Naveed$13MFollowers@naveed06/07/2023Bought to close 34% LPTX62.60% GAINLeap Therapeutics at $0.65 0123456789
Naveed$13MFollowers@naveed06/07/2023Bought to close 53% LPTX62.60% GAINLeap Therapeutics at $0.65 0123456789
Naveed$13MFollowers@naveed06/07/2023Bought to close 111% LPTX62.60% GAINLeap Therapeutics at $0.65 0123456789
Mike Pelech$11.2MFollowers@mpelech08/30/2022Sold all LPTX-6.03% LOSSLeap Therapeutics at $1.40 0123456789
Mike Pelech$11.2MFollowers@mpelech08/26/2022Sold 30% of LPTX11.41% GAINLeap Therapeutics at $1.66 0123456789
Mike Pelech$11.2MFollowers@mpelech08/24/2022New position in LPTXLeap Therapeutics at $1.49 0123456789
Abilash Satya$11.4MFollowers@abilash06/29/2022Sold all LPTX22.44% GAINLeap Therapeutics at $1.21 0123456789
Abilash Satya$11.4MFollowers@abilash06/29/2022Sold 50% of LPTX22.44% GAINLeap Therapeutics at $1.21 0123456789
Abilash Satya$11.4MFollowers@abilash06/16/2022Bought 100% more LPTXLeap Therapeutics at $0.99 0123456789
Abilash Satya$11.4MFollowers@abilash06/16/2022New position in LPTXLeap Therapeutics at $0.99 0123456789
Abilash Satya$11.4MFollowers@abilash02/17/2022Sold all LPTX-10.80% LOSSLeap Therapeutics at $2.23 0123456789
Abilash Satya$11.4MFollowers@abilash02/11/2022New position in LPTXLeap Therapeutics at $2.50 0123456789